Literature DB >> 15986226

Delayed or late-onset type II glycogenosis with globular inclusions.

Mehar C Sharma1, Christoph Schultze, Arpad von Moers, Gisela Stoltenburg-Didinger, Yoon S Shin, Teodor Podskarbi, Klaus Isenhardt, Dominique S Tews, Hans H Goebel.   

Abstract

Three unrelated patients, one girl, one boy, and an adult female, aged 14, 11 and 41 years, respectively, at the time of biopsy, revealed lysosomal glycogen storage, autophagic vacuoles and peculiar globular inclusions of distinct ultrastructure, which were reducing but did not appear like true "reducing bodies" as described in the congenital myopathy "reducing body myopathy". All three patients had residual activity of acid alpha-glucosidase in their muscle biopsy samples. Leukocytes in the girl showed normal acid alpha-glucosidase activity, but in the boy activity was reduced. Molecular genetic analysis of the GAA gene revealed disease-causing mutations in each patient: H568L/R672W, IVS1-13T>G/G615F, and IVS1-13T>G/IVS1-13T>G. Although only one patient with such globular inclusions has been reported up to now, the three patients described here indicate that in the late-onset type of GSD II such inclusions may not be rare.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986226     DOI: 10.1007/s00401-005-1026-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Molecular diagnosis of German patients with late-onset glycogen storage disease type II.

Authors:  P R Joshi; D Gläser; S Schmidt; M Vorgerd; M Winterholler; K Eger; S Zierz; M Deschauer
Journal:  J Inherit Metab Dis       Date:  2008-07-10       Impact factor: 4.982

2.  Identification and Functional Characterization of GAA Mutations in Colombian Patients Affected by Pompe Disease.

Authors:  Mónica Yasmín Niño; Heidi Eliana Mateus; Dora Janeth Fonseca; Marian A Kroos; Sandra Yaneth Ospina; Juan Fernando Mejía; Jesús Alfredo Uribe; Arnold J J Reuser; Paul Laissue
Journal:  JIMD Rep       Date:  2012-04-19

Review 3.  Acid alpha-glucosidase deficiency (Pompe disease).

Authors:  Tokiko Fukuda; Ashley Roberts; Paul H Plotz; Nina Raben
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

4.  A study of glycogen storage disease with 99Tcm-MIBI gated myocardial perfusion imaging.

Authors:  L G Wei; J Q Gao; X M Liu; J M Huang; X Z Li
Journal:  Ir J Med Sci       Date:  2013-04-25       Impact factor: 1.568

5.  A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations.

Authors:  Andreas Herzog; Ralf Hartung; Arnold J J Reuser; Pia Hermanns; Heiko Runz; Nesrin Karabul; Seyfullah Gökce; Joachim Pohlenz; Christoph Kampmann; Christina Lampe; Michael Beck; Eugen Mengel
Journal:  Orphanet J Rare Dis       Date:  2012-06-07       Impact factor: 4.123

6.  The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients.

Authors:  Erin J Feeney; Stephanie Austin; Yin-Hsiu Chien; Hanna Mandel; Benedikt Schoser; Sean Prater; Wuh-Liang Hwu; Evelyn Ralston; Priya S Kishnani; Nina Raben
Journal:  Acta Neuropathol Commun       Date:  2014-01-02       Impact factor: 7.801

7.  Familial adult-onset Pompe disease associated with unusual clinical and histological features.

Authors:  Lorenzo Maggi; Franco Salerno; Cinzia Bragato; Simona Saredi; Flavia Blasevich; Elio Maccagnano; Barbara Pasanisi; Cesare Danesino; Marina Mora; Lucia Morandi
Journal:  Acta Myol       Date:  2013-10

Review 8.  Pompe disease: from pathophysiology to therapy and back again.

Authors:  Jeong-A Lim; Lishu Li; Nina Raben
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.